David A. Siegel Inari Medical, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Inari Medical, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 76,100 shares of NARI stock, worth $3.73 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,100
Previous 26,900
182.9%
Holding current value
$3.73 Million
Previous $1.3 Million
142.24%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NARI
# of Institutions
262Shares Held
56.5MCall Options Held
90.4KPut Options Held
27.3K-
Black Rock Inc. New York, NY8.36MShares$410 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$274 Million0.0% of portfolio
-
Hcc Manager LLC Chicago, IL2.91MShares$143 Million91.04% of portfolio
-
Alliancebernstein L.P. New York, NY2.15MShares$105 Million0.03% of portfolio
-
State Street Corp Boston, MA2.04MShares$99.7 Million0.0% of portfolio
About Inari Medical, Inc.
- Ticker NARI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,389,700
- Market Cap $2.62B
- Description
- Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...